bf/NASDAQ:GBT_icon.jpeg

NASDAQ:GBT

Global Blood Therapeutics, Inc.

  • Stock

USD

Last Close

68.48

04/10 20:00

Volume Today

3.28M

Avg: -

PE Ratio

−27.41

PFCF: -

OverviewFinancialsAPI
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
asset turnover
0.00
-
0.17
6,357.85%
0.21
21.26%
cash conversion cycle
-70.60K
-
3.94K
105.58%
4.80K
21.86%
cash per share
3.78
-
11.60
206.47%
4.43
61.75%
7.44
67.72%
9.34
25.51%
10.46
12.03%
9.14
12.56%
10.88
18.99%
company equity multiplier
-1.13
-
1.09
196.18%
1.09
0.08%
1.12
3.00%
1.08
3.63%
1.38
27.58%
1.74
26.46%
4.78
174.86%
days of inventory outstanding
9.71K
-
7.39K
23.87%
6.41K
13.34%
days of payables outstanding
80.76K
-
3.51K
95.66%
1.66K
52.61%
days of sales outstanding
456.60
-
51.59
88.70%
53.98
4.62%
dividend yield
ebit per revenue
-133.44
-
-1.96
98.53%
-1.48
24.79%
ebt per ebit
1.01
-
1.00
1.49%
0.99
0.72%
0.98
1.08%
0.95
2.87%
0.95
0.51%
1.02
7.34%
1.05
3.33%
effective tax rate
-0.00
-
enterprise value multiple
-26.87
-
-5.84
78.27%
-4.77
18.23%
-12.72
166.40%
-10.76
15.41%
-17.17
59.58%
-10.20
40.57%
-6.52
36.07%
fixed asset turnover
0.03
-
1.40
5,195.28%
2.35
68.06%
free cash flow per share
-1.49
-
-2.49
67.58%
-2.08
16.45%
-2.27
9.18%
-2.74
20.68%
-3.39
23.79%
-3.60
6.02%
-4.13
14.89%
gross profit margin
0.98
-
0.98
0.69%
0.98
0.10%
interest coverage
-24.79
-
-18.60
24.97%
inventory turnover
0.04
-
0.05
31.36%
0.06
15.39%
long term debt to capitalization
0.11
-
0.26
133.56%
0.77
191.96%
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1.00
0.16%
net profit margin
-126.55
-
-2.00
98.42%
-1.56
22.17%
operating cash flow per share
-1.46
-
-2.41
64.97%
-2.04
15.45%
-2.20
7.77%
-2.65
20.42%
-3.33
25.96%
-3.45
3.62%
-4.08
18.15%
operating cycle
10.17K
-
7.44K
26.78%
6.46K
13.21%
operating profit margin
-133.44
-
-1.96
98.53%
-1.48
24.79%
payables turnover
0.00
-
0.10
2,203.41%
0.22
111.00%
pretax profit margin
-126.55
-
-2.00
98.42%
-1.55
22.29%
price fair value
-12.03
-
2.94
124.45%
2.58
12.42%
5.22
102.83%
3.67
29.83%
8.01
118.54%
6.38
20.32%
9.38
46.91%
receivables turnover
0.80
-
7.07
784.98%
6.76
4.42%
return on assets
-0.37
-
-0.30
18.84%
-0.41
34.54%
-0.33
19.49%
-0.28
14.03%
-0.34
18.81%
-0.34
2.04%
-0.32
5.62%
return on capital employed
-0.39
-
-0.33
15.44%
-0.44
36.49%
-0.36
18.88%
-0.31
13.26%
-0.39
24.02%
-0.38
2.87%
-0.34
10.36%
return on equity
0.42
-
-0.33
178.06%
-0.44
34.43%
-0.37
17.07%
-0.30
17.15%
-0.46
51.58%
-0.59
29.04%
-1.54
159.42%
total debt to capitalization
0.12
-
0.27
133.86%
0.77
185.76%

All numbers in USD (except ratios and percentages)